1. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy
- Author
-
Reza M. Mohamadi, Nidal Muhanna, Jonathan C. Irish, Jason L. Townson, Catriona M. Douglas, Donovan Eu, Marco A. Di Grappa, Scott V. Bratman, Shana O. Kelley, and Harley H.L. Chan
- Subjects
Male ,Cancer Research ,medicine.medical_treatment ,Rabbit ,Cottontail rabbit papillomavirus ,Open Reading Frames ,Circulating tumor cell ,Biomarkers, Tumor ,Genetics ,Carcinoma ,medicine ,Animals ,Liquid biopsy ,Head and neck cancer ,Lymph node ,RC254-282 ,Circulating tumor DNA ,Radiation ,VX2 ,Immunomagnetic Separation ,business.industry ,Liquid Biopsy ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Cancer ,Radiotherapy Dosage ,Epithelial Cell Adhesion Molecule ,medicine.disease ,Tumor Burden ,Radiation therapy ,medicine.anatomical_structure ,Oncology ,Head and Neck Neoplasms ,Carcinoma, Squamous Cell ,Cancer research ,Nanoparticles ,Mouth Neoplasms ,Oral cavity cancer preclinical model ,Rabbits ,business ,Cell-Free Nucleic Acids ,Neoplasm Transplantation ,Research Article ,Blood sampling - Abstract
Background Monitoring circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs), known as liquid biopsies, continue to be developed as diagnostic and prognostic markers for a wide variety of cancer indications, mainly due to their minimally invasive nature and ability to offer a wide range of phenotypic and genetic information. While liquid biopsies maintain significant promising benefits, there is still limited information regarding the kinetics of ctDNA and CTCs following radiation therapy which remains a vital treatment modality in head and neck cancers. This study aims to describe the kinetics of ctDNA and CTCs following radiation exposure in a preclinical rabbit model with VX2 induced buccal carcinoma. Methods Seven rabbits were inoculated with VX2 cells in the buccal mucosa and subjected to radiation. At selected time points, blood sampling was performed to monitor differing levels of ctDNA and CTC. Plasma ctDNA was measured with quantitative PCR for papillomavirus E6 while CTCs were quantified using an immunomagnetic nanoparticles within a microfluidic device. Comparisons of CTC detection with EpCAM compared to multiple surface markers (EGFR, HER2 and PSMA) was evaluated and correlated with the tumor size. Results Plasma ctDNA reflects the overall tumor burden within the animal model. Analysis of correlations between ctDNA with tumor and lymph node volumes showed a positive correlation (R = 0.452 and R = 0.433 [p Conclusion This study demonstrates the utility of ctDNA and CTCs detection in response to radiation treatment in a preclinical head and neck model, allowing for better understanding of liquid biopsy applications in both clinical practice and research development.
- Published
- 2021